Mon, 12/15/2025
Inside a lab, innovation can feel both exciting and uncertain. But for KU researchers, discovery may only be the beginning. Turning ideas into companies that create jobs, technologies, and growth in Kansas takes more than data—it takes courage, guidance, and a community that believes in what’s possible.
Mon, 11/24/2025
A new paper from the University of Kansas overturns the idea that a “risk gene” carried by millions of people worldwide influences production of Type 1 interferon, a workhorse of the immune system. ...
Tue, 11/11/2025
Researchers at the University of Kansas have discovered a human gene, the protein PARP14, plays a role in regulating interferon, part of the body’s innate immune system. Their study, appearing in journal mBio, could guide development of antiviral therapies for several groups of viral infection. ...
Tue, 10/07/2025
Dr. Robin Orozco is an Assistant Professor at the University of Kansas, where her lab studies how specific allelic variants affect immune responses. She talks about what we can learn from mouse models and the role of PTPN22 in antiviral immunity. (36:48)...
Wed, 09/17/2025
Zarko Boskovic, assistant professor of medicinal chemistry in the KU School of Pharmacy, has been awarded a $575,000 grant from the National Science Foundation. The grant will be used in the Boskovic Lab to shed light on the process of efficiently and selectively creating new molecules that hold potential for drug discovery.
Sat, 09/06/2025
University of Kansas researchers are working to use a machine-learning process to build new proteins designed to detect water pollutants.
Mon, 09/01/2025
Fehr awarded $2.2M from the NIH National Institute of General Medical Sciences.
Tue, 08/19/2025
The University of Kansas Center for Technology Commercialization (KUCTC) has selected six promising research projects for its inaugural Rock Chalk Ready program, a universitywide initiative designed to mature early-stage innovations and position them for commercialization success.
Fri, 08/01/2025
David Davido, Tony Fehr (Molecular Bioscience), received $411,500 from the NIH National Institute of Allergy and Infectious Diseases for a two-year R21 grant title, "Determining the role of PARP14 in restricting HSV-1 replication".
Tue, 07/22/2025
Dr. Anthony Fehr awarded $1 million dollar National Science Foundation grant titled "Determining how the evolution of the coronavirus macrodomain contributes to its biochemical and virological functions".
Wed, 07/16/2025
Six KU faculty members have been selected to participate in the Big 12 Faculty Fellowship over the summer and the upcoming academic year. These scholars will visit and collaborate with faculty and students across the Big 12 Conference.
Tue, 07/01/2025
A new study published in mBio details the vulnerability of coronaviruses to inhibitors of a small protein domain called Mac1, or the “macrodomain,” found in all coronaviruses such as SARS-CoV-2 and MERS-CoV.
Wed, 06/25/2025
Dr. Hyunjoon Kim's lab has published its first paper.
Mon, 06/23/2025
Robin Orozco, assistant professor of molecular biosciences, received a Stephen Benedict Most Impactful Professor Award from KU's Undergraduate Biology Program.
Fri, 05/23/2025
Chancellor Douglas A. Girod has approved the promotion and award of tenure, where indicated, for 44 individuals at the University of Kansas Lawrence and Edwards campuses and 114 individuals at the KU Medical Center campus.
Thu, 03/27/2025
“These four researchers have demonstrated excellence in their fields and have done so in a way that reflects well on our entire university. As one of the nation’s leading research institutions, KU strives to make discoveries that change the world — and these four scholars are helping us fulfill that mission every day," said Chancellor Douglas A. Girod.
Fri, 03/07/2025
The annual awards recognize outstanding unclassified academic staff, unclassified professional staff and postdoctoral fellows whose research significantly influenced their fields and expanded intellectual or societal insights.
Fri, 02/28/2025
Dr. Justin Hutchison, Dept. of Civil, Environmental, & Architectural Engineering, was awarded $620,001 by the Kansas Water Resources Institute.
Mon, 02/24/2025
Undergraduate researchers from the University of Kansas Lawrence and Medical Center campuses will present their research projects Feb. 26 as part of Kansas Undergraduate Research Day at the Capitol.
Fri, 01/31/2025
Former CBID project leader Dr. Josephine Chandler, Department of Molecular Biosciences, has been awarded an NIH grant for $2,162,077. Her project is titled "Quorum sensing evolution and function in mixed bacterial communities."
Fri, 01/31/2025
CBID graduate Dr. Shyam Sathyamoorthi, Department of Medicinal Chemistry, has been awarded $229,300 for a collaboration with Unio Biotech LLC.
Fri, 01/31/2025
Two KU professors — Anthony Fehr, associate professor of molecular biosciences, and Gibum Kwon, associate professor of mechanical engineering — were recently chosen for the PECASE Award, the highest honor given by the U.S. government to early-career researchers who show great potential for leading scientific advancements in the 21st century.
Tue, 12/31/2024
CBID graduate Dr. Robin Orozco, Department of Molecular Biosciences, wins a New Faculty Research Development Award ($5,000) for her project titled "Understanding the Benefits of the Commonly Expressed, Disease-causing Mutation of PTPN22."
Fri, 12/20/2024
A breakthrough in understanding how a single-cell parasite makes ergosterol (its version of cholesterol) could lead to more effective drugs for human leishmaniasis, a parasitic disease that inflicts about 1 million people and kills about 30,000 people around the world every year.
Tue, 11/26/2024
The University of Kansas is helping to develop both a Lyme disease vaccine and a Chlamydia vaccine with Lawrence born biotechnology lab, Design-Zyme, and the projects all started with help from a KU graduate student. Peter Petillo, Design-Zyme founder and CEO, and Professor Scott Hefty, from the KU school of molecular biosciences, act as the foundation for a partnership between university and industry.
Thu, 10/17/2024
The woods can be a place of adventure and beauty, a peaceful escape for a walk. But among the leaves and grass, the threat of ticks can turn a hike into a health-altering encounter with Lyme disease. A recent $3 million Small Business Innovation Research award will fund the research and development of a vaccine to stop Lyme disease in its tracks.
Thu, 10/03/2024
The Department of Chemistry congratulates Professor Jon Tunge on receiving the August 2024 Walter and Roy Cross Professional Service Award!
Mon, 09/30/2024
Hyunjoon Kim, CBID research project leader and Assistant Professor of Pharmaceutical Chemistry, was awarded $25,000 by University of Kansas Medical Center Research Institute to study "Novel TLR7/8 agonists for bladder cancer immunotherapy".
Mon, 09/30/2024
Shyam Sathyamoorthi, Associate Professor of Medicinal Chemistry and CBID research project leader graduate, won a new award from Kansas State University. This award will provide $76,500 to study "Illuminating Dark Antibiotics: A Novel Synthesis of Streptothricin F and First Total Synthesis of BD-12 and Albothricin".
Mon, 09/16/2024
Former CBID pilot project leader Wolfram Zückert awarded Chancellors Club Teaching Professorship at The University of Kansas Medical Center.